The Cancer of the Pancreas Screening-5 CAPS5)Study
Start Date
1/6/2014
Completion Date
6/1/2029
Summary
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Detailed Description
The Sub Investigator at each site will be responsible for internal monitoring at their site. The site sub Investigator and study team will report any serious adverse events to Principal Investigator and annually report adverse events.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Secretin
MRI
Tumor marker gene test with CA19-9
Conditions
Locations
Yale University
New Haven, Connecticut 06520
United States
Johns Hopkins Hospital
Baltimore, Maryland 21287
United States
Dana Farber Cancer Center, Harvard University
Boston, Massachusetts 02215
United States
University of Michigan
Ann Arbor, Michigan 48109
United States
NYU Langone Medical Center
New York, New York 10016
United States
Columbia University Medical Center
New York, New York 10032
United States
Case Comprehensive Cancer Center, Case Western Medical Reserve
Cleveland, Ohio 44106
United States
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
University of Pittsburgh
Pittsburgh, Pennsylvania 15213
United States